Os imunoensaios e os ensaios bioquímicos são amplamente utilizados em clinica médica. Os dispositivos fabricados em papel devido ao seu baixo custo, portabilidade, todas as etapas serem realizadas em temperatura ambiente, e possibilidade da produção local dos dispositivos, tornam-se ideais para serem aplicados em regiões carentes. Assim, desenvolvemos um ensaio imunocromatográfico que permitiu a detecção de IgG de coelho em um dispositivo com uma única camada de papel impressa por cera, mostrando que esse protótipo tem potencial de ser aplicado em diferentes ensaios imunológicos. Pela primeira vez foi utilizado um teste enzimático colorimétrico (sarcosina oxidase, peroxidase e o indicador redox (ABTS) em plataforma de papel, impressa por cera, para detecção de sarcosina, o qual detectou um potencial marcador de tumor de câncer de próstata, a sarcosina, com limite de detecção (LD) = 0,21 mmol L-1 e limite de quantificação (LQ) = 0,61 mmol L-1, constatando que a intensidade da cor formada foi proporcional a concentração de sarcosina presente na amostra. Os imunoensaios em papel se mostraram extremamente versáteis, capazes de detectar diferentes analitos. O primeiro dispositivo foi capaz de detectar toxoplasmose (IgG contra T. gondii presente nas amostras). A avaliação da performance do teste nos forneceu um cut-off =21,73 U.A, sensibilidade = 0,96, especificidade = 0,87, AUC = 0,97, além de uma criação de uma zona cinza utilizando uma tolerância em porcentagem sobre a o cut-off de 15%. Desenvolvemos também uma macro no excel qye calcula a acurácia, m-Acuraccy, a qual nos forneceu um valor de 0,88 U.A. O segundo dispositivo permitiu a detecção do marcador tumoral CEA, através de um ensaio do tipo sanduíche, com um cut-off =68,28 U.A, sensibilidade = 0,86, especificidade = 1, AUC = 0,97. A tolerância em porcentagem sobre a o cut-off para a criação da zona cinza foi de 12%, e a m-Acuraccy calculou uma acurácia de 0,90 U.A. Pela primeira vez, foi aplicada essa completa avaliação estatística em testes em papel. Mais do que isso, trazemos com a m-Acuraccy uma nova forma de calcular a acurácia, com grande inovação na clínica médica. Portanto, torna-se evidente o grande potencial que os dispositivos fabricados em papel possuem para ser aplicados como ferramentas diagnósticas. / Immunoassays and bioassays are broadly used in clinical medicine. Paper-based devices are ideal to be used in remote regions due to their low-cost, portability and the possibility of in loco manufacture. Paper-based immunoassays are extremely versatile, capable of detecting distinct analytes: initially we have developed an immunochromatographic assay to detect rabbit IgG in a paper-based device fabricated using wax printing technology, and we have shown that this prototype has potential to be applied in distinct immunoassays. The second developed paper-based device was an enzymatic colorimetric assay for the detection of a potential prostate cancer biomarker - sarcosine (sarcosine oxidase, peroxidase and redox indicator (ABTS)), obtaining good figures or merit (LOD = 0.21 mmol L-1; LOQ = 0.61 mmol L-1, r² = 0.890). The third developed paper-based device was capable of detecting toxoplasmosis (IgG against Toxoplasma gondii in human serum samples). The performance evaluation showed a cut-off = 21.73 A.U., sensitivity = 0.96, specificity = 0.87, AUC = 0.97, besides defining the gray zone as the zone comprehended in-between 15% over the cut-off value. We also have developed a Microsoft Excel® macro to calculate diagnostic test\'s accuracy - m-Accuracy - that is a new way to calculate accuracy with great innovation for clinical medicine, which resulted in an accuracy of 0.88. for toxoplasmosis assay. The fourth developed paper-based device was used to detect CEA tumor biomarker using a sandwich ELISA assay, with a cut-off = 68.28 A.U., sensitivity = 0.86, specificity = 1.0, AUC = 0.97. The defined gray zone to this test was the zone comprehended in-between 12% over the cut-off value, with an accuracy of 0.90. To the best of our knowledge, this is the first complete statistical evaluation of paper-based diagnostic devices, which showed the great potential of this technology to be used as a new point-of care diagnostic tool.

L’objectif général de cette thèse concerne la mise en place et l’évaluation d’une approche de type effect directed analysis (EDA), couplant bioessais in vitro et analyses physico-chimiques, pour la caractérisation de la contamination des milieux aquatiques par les perturbateurs endocriniens (PE) et leur identification. De nouveaux outils in vitro ont été développés et intégrés à une approche multi-bioessais pour la détection de polluants émergents afin de permettre un large diagnostic de la contamination par les PE. Parmi eux, le bioessai basé sur le pregnane X receptor humain s’est avéré complémentaire des cibles classiquement étudiées (e.g. récepteurs des œstrogènes (ER), des androgènes (AR) ou des hydrocarbures aromatiques (AhR)). Combinés, ces bioessais ont permis de déterminer des profils intégrés de la contamination inédits dans le sédiment et les eaux de surface, mettant en lumière la nécessité de considérer d’autres cibles biologiques que ER et AhR et de s’intéresser à l’ensemble des compartiments du milieu aquatique pour une meilleure évaluation de la contamination. En particulier, l’utilisation combinée de ces nouveaux outils à des capteurs passifs de type POCIS (polar organic compound integrative sampler) s’est révélée pertinente pour évaluer la contamination de la colonne d’eau par des composés hydrosolubles. Enfin, une démarche EDA, intégrant ces bioessais et des méthodes physico-chimiques d’extraction et de fractionnement adaptées, a été validée pour l’identification des composés détectés. Son application sur deux sites soumis à des contaminations chimiques différentes (mixte urbaine/agricole et pharmaceutique) a permis d’évaluer la contribution des polluants cibles, dont les prioritaires, dans les réponses des bioessais et d’identifier de nouveaux PE. / The aim of this thesis was to develop and to evaluate an effect directed analysis (EDA) approach, combining in vitro bioassays and chemical analysis for the characterization of aquatic systems contamination by endocrine disrupting chemicals (EDCs) and their identification. For integrative contamination assessment, new in vitro tools have been developed and evaluated for the detection of emerging pollutants, and then integrated in a multi-bioassays approach. In particular, the human pregnane X receptor (PXR) based bioassay provided further information on bioactive contaminants and thereby enhanced the environmental diagnostic as regard to classical biological target (e.g. estrogen (ER), androgen (AR) or aryl hydrocarbon receptors (AhR)). Such multi-receptors approach allowed determining novel integrative toxicity profiles in sediment and surface water. Overall, our results demonstrated the need to integrate other biological target than ER and AhR, and to assess contamination partitioning for a better hazard/risk assessment. For such purpose, combined use of polar organic compound integrative sampler and in vitro bioassays provided suitable tools to assess active hydrosoluble chemicals in surface water. Finally, in order to identify the compounds responsible for the detected activities, the multi-receptors approach has been integrated in EDA strategy applied to two river sites under different chemical pressures (urban/agricultural and pharmaceutical). To tackle this challenge, extraction and fractionation methods were developed and evaluated in order to encompass a diversity of active chemicals that are detected by in vitro bioassays. The EDA approach allowed determining partial contribution of priority pollutants in biological responses as well as the identification of new EDCs.

Over the last few decades, membrane introduction mass spectrometry (MIMS) has been established as a robust tool for the on-line continuous monitoring of trace gases and volatile organic compounds. However, the range of amenable anlaytes has been limited by the need for molecules to pervaporate into a gaseous acceptor phase, or high vacuum environment of a mass spectrometer. This thesis expands the range of amenable analytes for MIMS to include larger, less volatile molecules (e.g., 200 to 500 Da), such as pharmaceuticals, persistent organic pollutants, and small biomolecules. This was achieved through the use of a liquid|membrane|liquid interface. We distinguish the technique from conventional MIMS, which uses a gaseous acceptor phase, by inserting the prefix ‘condensed phase’ to emphasize the use of a solvent acceptor phase – thus yielding CP-MIMS. An initial flow-cell interface with a methanol acceptor phase was characterized, yielding detection limits for model analytes in pptr to ppb, and analyte response times from 1-10 minutes. The flow cell interface was miniaturized into an immersion style CP-MIMS probe (~2 cm), which allowed for analysis of smaller volume samples and improved membrane washing capabilities. Comparable detection limits were observed for the immersion probe, however, it was noticed that significant analyte depletion was observed for samples under 2 mL. In addition, each of the developed membrane interfaces were observed to suffer from ionization suppression effects from complex samples when paired with ESI. Several strategies for mitigating ionization suppression using CP-MIMS are presented, including the use of a continuously infused internal standard present within the acceptor solvent. The developed CP-MIMS system was challenged with the analysis of naphthenic acids (a complex mixture of aliphatic carboxylic acids) directly in contaminated real-world samples. The method used negative ESI to rapidly screen and mass profile aqueous samples for naphthenic acids (as [M-H]-), with sample duty cycles ~20 min. However, it was found that Negative ESI did not differentiate hydroxylated and carboxylated analytes, and both species contributed signal to the total naphthenic acid concentration. To increase method specificity for carboxylic acids, barium ion chemistry was used in conjunction with positive ion tandem mass spectrometry. Common product ions were used to quantify carboxylated analytes, while a qualifier ion was used to confirm the functionality. The increased selectivity afforded by the barium ion chemistry was at the cost of a modest increase in detection limits. CP-MIMS has been established as a technique capable of the direct analysis of real-world samples, and shows promise as a rapid screening method for amenable environmental contaminants and/or biomolecules. / Graduate / 0486 / 0485 / kyle.duncan@viu.ca

A mistura triterpênica ¤ e ß- amirinas é comumente encontrada em quantidades significativas em espécies do gênero Protium (Burseraceae) e possuem reconhecidas atividades anti-inflamatória, hepatoprotetora, gastroprotetora e analgésica, dentre outras. Entretanto, pouco se sabe sobre sua farmacocinética e metabolismo. Neste sentido, esta tese teve o objetivo de desenvolver metodologias bioanalíticas para determinar a farmacocinética e a eliminação de ? e ?-amirinas isoladas de P. spruceanum bem como avaliar o metabolismo in vitro destes triterpenos. A mistura de ¤ e ß-amirinas foi isolada em grau de pureza cromatográfica acima de 99%. Foi desenvolvida e caracterizada uma nanoemulsão do tipo O/A contendo ¤ e ß-amirinas a fim de viabilizar a administração por vias oral e endovenosa e realizar os estudos de disposição cinética dessas substâncias em camundongos. O tamanho médio das partículas da nanoemulsão foi de 103,5 ± 0,44 nm, com porcentagem de encapsulação de acima de 99%. Os estudos de liberação in vitro mostraram baixa taxa de liberação após 24 horas. A avaliação da disposição cinética de ? e ?-amirinas em camundongos mostrou que após administração oral a suspensão de CMC não foi absorvida, entretanto a nanoemulsão contendo as substancias foi absorvida e a biodisponibilidade oral de ¤ e ß-amirinas foi de 1,03 ± 0,08 e 1,56 ± 0,24%, respectivamente. O Vd foi elevado e a T1/2 foi de 2,61±0,15 e 2,57±0,07 horas, respectivamente. O ClB mostrou-se elevado, comparado ao ClR. Após administração oral da nanoemulsão, praticamente toda a mistura foi eliminada inalterada nas fezes devido a baixa absorção. Entretanto, após administração endovenosa cerca de 50% da mistura foi eliminada inalterada pela via biliar. Estudos de eliminação renal de ¤ e ß-amirinas mostraram que apenas cerca de 0,2% das substâncias foram eliminadas por via renal após administração endovenosa. O fenômeno Flip-Flop ocorreu para a via extravascular utilizada. Os resultados da eliminação parcial e de baixa liberação in vitro sugerem que após administração endovenosa da nanoemulsão pode ocorrer acúmulo extravascular dos compostos, corroborando com altos Vd. As reações biomiméticas de oxidação de ¤ e ß-amirinas mostraram baixa taxa degradação. Apenas um metabólito putativo foi encontrado, entretanto, não foi possível observá-lo nas matrizes biológicas analisadas. / The triterpene mixture of ¤ and ß-amyrins is generally found in significative amounts in Protium species (Burseraceae). They have known biological activities as anti-inflammatory, hepatoprotective, gastroprotective and antinociceptive effects among others. However, their pharmacokinetics and metabolism are practically unknown. The purpose of this thesis was to develop bioanalytical methodologies to perform pharmacokinetic and elimination studies of ¤ and ß-amyrins from P. spruceanum as well as to evaluate in vitro metabolism of these triterpenes. The mixture ¤ and ß-amyrins was isolated with chromatography purity above 99%. One ¤ and ß-amyrins loaded O/W nanoemulsion was developed and characterized to enable the intravenous and oral administration and to performed pharmacokinetic studies of these compounds in mice. The average particle size was 103.5 ± 0.44 nm and the encapsulation efficiency was higher than 99%. In vitro release study demonstrated low release rater after 24 hours. The pharmacokinetics studies of ? and ?-amyrins indicated CMC suspension was not absorbed, however ¤ and ß-amyrins loaded O/W nanoemulsion was poorly absorved and bioavailability was 1.03 ± 0.08 and 1.56 ± 0.24% respectively. The Vd was high and T1/2 was 2.61 ± 0.15 e 2.57± 0.07 hours respectively. The ClB was high compared to ClR. After oral administration almost all ¤ and ß-amyrins were eliminated unchanged in faeces due to low absorption. However, after intravenous administration about 50% was excluded unchanged by biliar excretion pathway. Studies of ¤ and ß-amyrins renal elimination directed only 0.2 % were removed unchanged by renal pathway after intravenous administration. The Flip-Flop phenomenon was happen when ¤ and ß- amyrins was dispensed by extravascular via. The partial biliar excretion in vivo and low release rate in vitro suggests ¤ and ß-amyrins could be stored after nanoemulsion intravenous administration confirming high Vd. The biomimetic reactions of oxidation of ¤ and ß-amyrins showed low degradation rate and only one metabolite was found however it was not detected in biological samples.

O gênero Piper pertencente à família Piperaceae, encontra-se distribuído nas regiões tropicais e subtropicais do globo. Estudos químicos têm demonstrado diversidade de metabólitos secundários com atividade biológica. Os alcalóides são metabólitos característicos. A piplartina, (E)-1-(3-(3,4,5-trimetoxifenil)acriloil)-5,6- diidropiridin-2(1H)-ona, é um alcalóide encontrado em muitas espécies. Tem atividade citotóxica contra células de linhagem tumoral, ansiolítica, antidepressiva, antifúngica e antiagregação plaquetária, sendo dessa forma, uma molécula candidata a um novo fármaco. O conhecimento do metabolismo de um candidato a fármaco é um fator importante na avaliação da sua segurança e eficácia. Ensaios in vitro estão crescentemente sendo utilizados como screening e os microssomas hepáticos representam o sistema in vitro mais utilizado. Dessa forma, o presente trabalho tem como objetivo determinar os parâmetros cinéticos enzimáticos in vitro da piplartina utilizando microssomas de fígado de ratos, bem como a determinação dos possíveis metabólitos formados. Para tanto, foi desenvolvido um método de quantificação da piplartina utilizando cromatografia líquida de alta eficiência. Como condição de análise, empregou-se uma coluna C18, fase móvel acetonitrila:água (40:60, v/v) e vazão de 1 mL min-1. Para extração da piplartina dos microssomas hepático de ratos foi empregado a extração líquido-líquido utilizando 4,0 mL de hexano como solvente extrator. Após otimização da extração, o método foi validado, mostrando-se linear na faixa de 2,4-157,7 ?M, obtendo-se uma equação da reta y= 0,0934x + 0,0027, (r= 0,99) e limite de quantificação de 2,4 ?M. A recuperação média foi de 85%. A precisão e exatidão apresentaram resultados dentro do recomendável pela ANVISA. A piplartina manteve-se estável até 50 minutos em condições de incubação, e até 6h sob a bancada. Após validação da metodologia, estabeleceram-se as condições lineares para a quantidade de proteínas microssomais: 0,28 mg mL-1 e para o tempo de incubação: 16 minutos no consumo da piplartina no meio microssomal, e então efetuou-se a determinação dos parâmetros cinéticos enzimáticos da piplartina empregando as condições de V0. Nesse estudo foi observado um Vmax= 4,74 ± 0,26 ?M/?g mL-1/min, h= 2,53 ± 0,37, S50= 44,69 ± 0,32 ?M e CLmax= 0,054 ?L/min/mg proteina, um perfil cinético indicativo de cooperatividade. Um estudo qualitativo para determinação dos possíveis metabólitos foi feito utilizando-se a espectrometria de massas, por meio da qual foi possível identificar a formação de dois produtos hidroxilados. Deste modo, os microssomas mostraram-se uma ferramenta útil, rápida e simples para determinação da cinética enzimática, e na condução dos estudos preliminares de metabolismo in vitro. / The genus Piper belongs to the Piperaceae family and includes species that are widely distributed throughout the tropical and subtropical regions of the world. Chemical studies have shown diversity of secondary metabolites with biological activity. The alkaloids are characteristic metabolites. The piplartine, (E)-1-(3-(3,4,5- trimethoxyphenyl)acryloyl)-5,6-diidropiridin-2(1H)-one is an alkaloid found in many species. It shows cytotoxic activity against tumor cell lines, anxiolytic, antidepressant, antifungal, and antiplatelet therapy, thus being a drug candidate. The knowledge regarding the oxidative metabolism is an important tool in assessing the safety and efficacy of a drug candidate. In vitro assays are increasingly being used as a screening tool and liver microsomes represent the most widely in vitro system used for that. This study aims to determine the in vitro enzymatic kinetic parameters for piplartine by cytochrome P450 enzymes (CYP) present in the rat liver microsomes, and the determination of possible metabolites. To accomplish, it was developed a method to quantify the piplartine using high performance liquid chromatography. The analysis was carried out employing a C18 column, mobile phase: acetonitrile: water (40:60, v/v) at a flow rate of 1 ml min-1. To extract piplartine from rat liver microsomes it was employed the liquid-liquid extraction (4.0 mL of hexane). The method was validated and proved to be linear in the range of 2.4 to 157.7 ?M, the equation for calibration curve was: y= 0.0934x + 0.0027 (r = 0.99), and a limit of quantification of 2.4 ?M. The mean recovery was 85%. The precision and accuracy were in agreement with ANVISA guidelines. The piplartine remained stable until 50 minutes of incubation conditions, and until 6 hours under the bench. Once validated, it was set the conditions for the linear amount of microsomal protein: 0.28 mg mL-1 and to the incubation time: 16 minutes, then it was performed the determination of enzymatic kinetic parameters, that revealed a sigmoidal profile with Vmax = 4.74 ± 0.26 ?M/mg mL-1/min, h = 2.53 ± 0.37, S50 = 44.69 ± 0.32 ?M, and CLmax = 0.054 ?L/min/mg protein, indicating a cooperativity behavior. A qualitative study to determine possible metabolites carried out using mass spectrometry, through which it was possible to identify the formation of two hydroxylated products. To conclude, the microsomes showed to be a useful, fast and simple tool to determination of enzymatic kinetics and in vitro metabolism studies.

A Agência Nacional de Vigilância Sanitária (ANVISA) não exige a realização de ensaios de bioequivalência utilizando métodos enantiosseletivos de quantificação de fármacos para o registro de medicamentos genéricos ou similares contendo fármacos racêmicos. Porém, existe a possibilidade das diferenças de concentrações plasmáticas dos enantiômeros entre o medicamento referência e os genéricos e/ou similares comercializados no Brasil serem maiores que as estabelecidas pelos limites de bioequivalência. Esse estudo teve a finalidade de investigar a influência da velocidade de liberação do fármaco metoprolol, a partir da forma farmacêutica, sobre o processo de absorção do fármaco total e de seus enantiômeros por meio da avaliação das concentrações plasmáticas de metoprolol total, (S)-metoprolol e (R)-metoprolol, e da relação entre as concentrações dos enantiômeros (S/R) após a administração oral de medicamentos contendo mistura racêmica deste fármaco. Para isso, foi realizado ensaio de biodisponibilidade in vivo, em um grupo de 20 voluntários saudáveis, de acordo com procedimentos éticos estabelecidos internacionalmente. Foram empregados três esquemas de administração do metoprolol, com a finalidade de simular diferentes velocidades de liberação do fármaco a partir da forma farmacêutica, na Fase 1 foi administrado uma dose única de 100 mg de metoprolol em solução, na Fase 2 e Fase 3 essa mesma dose foi particionada em duas e cinco administrações, respectivamente, com intervalo de 30 minutos entre elas. Foram coletadas amostras de sangue, e estas foram analisadas utilizando método convencional e método quiral para quantificação do metoprolol total e seus enantiômeros, respectivamente, utilizando cromatografia líquida de alta eficiência, com detector de fluorescência. Os parâmetros farmacocinéticos de ASC0-t, Cmáx e Tmáx foram utilizados para comparação entre as três velocidades de liberação do fármaco a partir da forma farmacêutica. A análise farmacocinética para o fámaco (R,S) metoprolol e seus enantiômeros e a comparação entre seus parâmetros farmacocinéticos obtidos após administração oral do metoprolol, indicam uma cinética enantioseletiva para o metoprolol, que pode ter ocorrido devido a uma biotransformação pré-sistêmica dose-dependente, ou a uma inibição do metabolismo do (S)-metoprolol pela forma (R)-metoprolol. / ANVISA, brazilian regulatory agency for drug products, does not require the use of enantioselective bioanalytical methods in bioequivalence assays of generic and similar drug products containing racemic drugs. Therefore, it is possible that two formulations are bioequivalent based on plasmatic concentration of total drug, but are not bioequivalent on the basis of the comparison of the data of the stereoisomers. The objective of this study was to investigate the influence of the release rate of metoprolol from the dosage form on its absorption process and on its enantiomers\' absorption process by measuring plasmatic concentrations of total metoprolol, (S)-metoprolol and (R)-metoprolol after oral administration of drug products containing racemic metoprolol. An in vivo bioavailability study was conducted in a group of 20 healthy volunteers, according to national and international guidelines for biomedical research, in which the administration rate of metoprolol was varied. In Phase 1 a single dose of 100 mg metoprolol was administered in solution, in Phase 2 and Phase 3 the same dose was partitioned into two and five administrations, respectively, with an interval of 30 minutes between them. Blood samples were collected, and these were analyzed using the conventional method and chiral method for quantification of (R,S)-metoprolol and for its enantiomers, using high performance liquid chromatography with fluorescence detection. The pharmacokinetic parameters AUC0-t, Cmax and Tmax were used for comparisons between three different drug release rates. Pharmacokinetic analysis for (R, S) metoprolol and its enantiomers and comparison of their pharmacokinetic parameters obtained after oral administration of metoprolol, to indicate an enantioselective kinetic, which may be due to a biotransformation pre-systemic dose dependent or the inhibition of metabolism of the (S)-form for metoprolol (R)-metoprolol.

A Agência Nacional de Vigilância Sanitária (ANVISA) não exige a realização de ensaios de bioequivalência utilizando métodos enantiosseletivos de quantificação de fármacos para o registro de medicamentos genéricos ou similares contendo fármacos racêmicos. Porém, existe a possibilidade das diferenças de concentrações plasmáticas dos enantiômeros entre o medicamento referência e os genéricos e/ou similares comercializados no Brasil serem maiores que as estabelecidas pelos limites de bioequivalência. Esse estudo teve a finalidade de investigar a influência da velocidade de liberação do fármaco metoprolol, a partir da forma farmacêutica, sobre o processo de absorção do fármaco total e de seus enantiômeros por meio da avaliação das concentrações plasmáticas de metoprolol total, (S)-metoprolol e (R)-metoprolol, e da relação entre as concentrações dos enantiômeros (S/R) após a administração oral de medicamentos contendo mistura racêmica deste fármaco. Para isso, foi realizado ensaio de biodisponibilidade in vivo, em um grupo de 20 voluntários saudáveis, de acordo com procedimentos éticos estabelecidos internacionalmente. Foram empregados três esquemas de administração do metoprolol, com a finalidade de simular diferentes velocidades de liberação do fármaco a partir da forma farmacêutica, na Fase 1 foi administrado uma dose única de 100 mg de metoprolol em solução, na Fase 2 e Fase 3 essa mesma dose foi particionada em duas e cinco administrações, respectivamente, com intervalo de 30 minutos entre elas. Foram coletadas amostras de sangue, e estas foram analisadas utilizando método convencional e método quiral para quantificação do metoprolol total e seus enantiômeros, respectivamente, utilizando cromatografia líquida de alta eficiência, com detector de fluorescência. Os parâmetros farmacocinéticos de ASC0-t, Cmáx e Tmáx foram utilizados para comparação entre as três velocidades de liberação do fármaco a partir da forma farmacêutica. A análise farmacocinética para o fámaco (R,S) metoprolol e seus enantiômeros e a comparação entre seus parâmetros farmacocinéticos obtidos após administração oral do metoprolol, indicam uma cinética enantioseletiva para o metoprolol, que pode ter ocorrido devido a uma biotransformação pré-sistêmica dose-dependente, ou a uma inibição do metabolismo do (S)-metoprolol pela forma (R)-metoprolol. / ANVISA, brazilian regulatory agency for drug products, does not require the use of enantioselective bioanalytical methods in bioequivalence assays of generic and similar drug products containing racemic drugs. Therefore, it is possible that two formulations are bioequivalent based on plasmatic concentration of total drug, but are not bioequivalent on the basis of the comparison of the data of the stereoisomers. The objective of this study was to investigate the influence of the release rate of metoprolol from the dosage form on its absorption process and on its enantiomers\' absorption process by measuring plasmatic concentrations of total metoprolol, (S)-metoprolol and (R)-metoprolol after oral administration of drug products containing racemic metoprolol. An in vivo bioavailability study was conducted in a group of 20 healthy volunteers, according to national and international guidelines for biomedical research, in which the administration rate of metoprolol was varied. In Phase 1 a single dose of 100 mg metoprolol was administered in solution, in Phase 2 and Phase 3 the same dose was partitioned into two and five administrations, respectively, with an interval of 30 minutes between them. Blood samples were collected, and these were analyzed using the conventional method and chiral method for quantification of (R,S)-metoprolol and for its enantiomers, using high performance liquid chromatography with fluorescence detection. The pharmacokinetic parameters AUC0-t, Cmax and Tmax were used for comparisons between three different drug release rates. Pharmacokinetic analysis for (R, S) metoprolol and its enantiomers and comparison of their pharmacokinetic parameters obtained after oral administration of metoprolol, to indicate an enantioselective kinetic, which may be due to a biotransformation pre-systemic dose dependent or the inhibition of metabolism of the (S)-form for metoprolol (R)-metoprolol.

Submitted by Cássia Santos (cassia.bcufg@gmail.com) on 2014-09-09T11:45:33Z No. of bitstreams: 2 Dissertacao_Lorena_Maione_Silva_Ciencias_Farmaceuticas.pdf: 516603 bytes, checksum: ec25498f249629c65bc31a3ef2bd8588 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2014-09-09T11:45:33Z (GMT). No. of bitstreams: 2 Dissertacao_Lorena_Maione_Silva_Ciencias_Farmaceuticas.pdf: 516603 bytes, checksum: ec25498f249629c65bc31a3ef2bd8588 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2012-02-28 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / Genistein (GEN), isoflavone contained in soybeans, shows activity against a large number of cancers, including skin cancer. However, to be used topically it is essential the association of GEN in an appropriate formulation. The aim of this study was the development and characterization of solid lipid nanoparticles (SLN) contends genistein for topical application. A bioanalytical method was developed and validated for GEN quantification in skin layers with High Performance Liquid Chromatographer (HPLC) with UV detection. The SLN was obtained with glyceryl behenate, polysorbate 80, sorbitan trioleate and different amounts of cetylpyridinium chloride (CPC) (0.5 - 0.05%). The characteristics in terms of particle size, size distribution, zeta potential, entrapment efficiency and drug recovery were evaluated. In vitro release, passive and iontophoretic, skin permeation studies were performed. Cytotoxicity studies were carried out in melanoma cells (B16F10) with free drug and SLN with and without GEN. The analytical method was linear in the concentration range of 0.1 to 60 mg/mL. Limit of quantification was 100 ng/mL for both skin layers. Recovery of the drug ranged from 95.57 to 97.57%. The method was able to analyze the GEN without suffering interference from endogenous skin components. SLN loaded with GEN showed positive surface (+ 23 mV) and average size of 343 nm. Particles were obtained with high entrapment efficiency (93%) and drug load was 5.45%. In vitro release studies demonstrated that the release of GEN from SLN occurs in two stages with a large amount of drug released within the first six hours, followed by a slow release of the remaining drug in the lipid matrix of SLN in the following hours. When administered in the skin, during in vitro passive permeation studies, the SLN increased retention of GEN in stratum corneum and remaining skin compared with free GEN. After iontophoresis application in formulation of SLN containing GEN thirteen times more GEN was retained on stratum corneum and three times more drug was retained on remaining skin. In cellular cytotoxicity studies SLN favored the increase of interaction of drug with the cells and the cytotoxicity was concentration-dependent. Thus, GEN loaded SLN increased drug skin permeation and retention and shows to be a potential formulation for topical application. / A genisteína (GEN), isoflavona contida nos grãos da soja, apresenta atividade contra um grande número de tipos de câncer, incluindo o câncer de pele. No entanto, para ser usada topicamente é fundamental que a GEN esteja associada a uma formulação adequada. O objetivo deste trabalho foi desenvolver e caracterizar nanopartículas lipídicas sólidas (NLS) contendo genisteína para aplicação tópica. Para a quantificação da genisteína nas diferentes camadas da pele foi desenvolvida e validada uma metodologia bioanalítica em cromatografia líquida de alta eficiência (CLAE) com detecção no UV. As NLS foram obtidas com behenato de glicerila, polissorbato 80, trioleato de sorbitano e tensoativo catiônico cloreto de cetilpiridínio (CPC) em diferentes quantidades (0,5 – 0,05%). As NLS foram caracterizadas quanto ao tamanho, PdI, potencial zeta, eficiência de encapsulação e recuperação. Foram realizados estudos in vitro de liberação e permeação cutânea passiva e iontoforética. Estudos de citotoxicidade foram realizados em linhagem de melanoma (B16F10) com fármaco livre e NLS com e sem GEN. O método de quantificação do fármaco mostrou-se linear na faixa de concentração de 0,1 a 60 μg/mL. O limite de quantificação foi de 100 ng/mL para ambas as camadas da pele. A recuperação do fármaco variou entre 95,57 a 97,57%. Ainda, o método foi capaz de analisar a GEN sem sofrer interferência dos componentes endógenos da pele. As NLS carregadas com fármaco apresentaram carga superficial positiva (+ 23 mV) e tamanho médio de 343 nm. Também foram obtidas partículas com alta eficiência de encapsulação (93%) e carga de fármaco de 5,45%. Os estudos de liberação in vitro demonstraram que a liberação da GEN a partir das NLS ocorre em duas fases, com uma grande quantidade de fármaco liberada nas seis primeiras horas, seguida por uma liberação lenta do restante do fármaco da matriz lipídica das NLS nas horas seguintes. Quando administrada na pele, nos estudos de permeação passiva in vitro, as NLS aumentaram a retenção da GEN tanto no estrato córneo quanto na pele remanescente em comparação à administração da GEN livre. Após a aplicação da iontoforese na formulação de NLS contendo GEN, treze vezes mais GEN ficou retida no EC e três vezes mais fármaco ficou retido na pele remanescente. Nos estudos de citotoxicidade, as NLS favoreceram o aumento da interação do fármaco com as células e a citotoxicidade foi concentração-dependente. Deste modo, a encapsulação da GEN em NLS aumentou a permeação e retenção do fármaco na pele, demonstrando assim, potencial para aplicação tópica.

In this dissertation, three different microfluidic devices with bioanalytical applications are presented. From chapter to chapter, the bioanalytical focus will gradually become the development of a point-of-care sensor platform able to yield a reliable and quantitative response in the presence of the desired target. The first device consists of photolithographically-patterned gold on glass bipolar electrodes and PDMS Y-shaped microchannels for the controlled enrichment, separation from a mixture, and delivery of two charged dyes into separate receiving microchannels. The principle for the permanent separation of these dyes is based on the concept of bipolar electrochemistry and depended on the balancing/unbalancing of convective and electromigrating forces caused by the application of a potential bias, as well as the activation/deactivation of the bipolar electrodes. Two different bipolar electrode configurations are described and fluorescence is used to optimize their efficiency, speed, and cleanliness of delivery. The second device is a DNA sensor fabricated on paper by wax printing and folding to form 3D channels. DNA is detected by strand-displacement induced fluorescence of a single-stranded DNA. A multiplexed version of this sensor is also shown where the experiment results in “OR” and “AND” Boolean logic gate operations. In addition, the nonspecific adsorption of the reagents to cellulose is studied, demonstrating that significant reduction of nonspecific adsorption and increased sensitivity can be achieved by pre-treating the substrate with bovine serum albumin and by preparing all analyte solutions with spectator DNA. The third device, also made of paper, has a novel design and uses a versatile electrochemical detection method for the indirect detection of analytes via the direct detection of AgNP labels. A proof-of-concept experiment is shown where streptavidin-coated magnetic microbeads and biotin-coated AgNPs are used to form a composite model analyte. The paper device, called oSlip, and electrochemical method used are easily coupled so the resulting sensor has a simple user-device interface. LODs of 767 fM are achieved while retaining high reproducibility and efficiency. The fourth device is the updated version of the oSlip. In this case, the objective is to show the current progress and limitations in the detection of real analytes using the oSlip device. A sandwich-type immunoassay approach is used to detect human chorionic gonadotrophin (pregnancy hormone) present in human urine. Various optimization steps are performed to obtain the ideal reagent concentrations and incubation time necessary to form the immunocomposite in one step, that is, by mixing all reagents at the same time in the oSlip. Additionally, improvements to the electrochemical detection step are demonstrated. / text

Biomolecular interaction analysis to determine the kinetics and affinity between interacting partners is important for the fundamental understanding of biology, as well as for the development of new pharmaceutical substances. A quartz crystal microbalance instrument suitable for kinetics and affinity analyses of interaction events was developed. The functionality of the sensor system was demonstrated by development of an assay for relative affinity determination of lectin-carbohydrate interactions. Sensor surfaces allowing for effective immobilization of one interacting partner is a key functionality of a biosensor. Here, three different surfaces and immobilization methods were studied. First, optimized preparation conditions for sensor surfaces based on carboxyl-terminated self assembled monolayers were developed and were demonstrated to provide highly functional biosensor surfaces with low non-specific binding. Second, a method allowing for immobilization of very acidic biomolecules based on the use of an electric field was developed and evaluated. The electric field made it possible to immobilize the highly acidic C-peptide on a carboxylated surface. Third, a method for antibody immobilization on a carboxyl surface was optimized and the influence of immobilization pH on the immobilization level and antigen binding capacity was thoroughly assessed. The method showed high reproducibility for a set of antibodies and allowed for antibody immobilization also at low pH. Three broadly different strategies to increase the sensitivity of electroacoustic sensors were explored. A QCM sensor with small resonator electrodes and reduced flow cell dimensions was demonstrated to improve the mass transport rate to the sensor surface. The use of polymers on QCM sensor surfaces to enhance the sensor response was shown to increase the response of an antibody-antigen model system more than ten-fold. Moreover, the application of high frequency thin film bulk acoustic resonators for biosensing was evaluated with respect to sensing range from the surface. The linear detection range of the thin film resonator was determined to be more than sufficient for biosensor applications involving, for instance, antibody-antigen interactions. Finally, a setup for combined frequency and resistance measurements was developed and was found to provide time resolved data suitable for kinetics determination. / wisenet